Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
CAR T-cellen gericht op Aspergillus fumigatus effectief in preklinische modellen
dec 2022 | Schimmelinfecties